乳腺癌 - 医索

找到约 32963 条结果

Three-year disease-free survival after transanal vsaparoscopic total mesorectal excision for rectalcancer (TaLaR)A randomized clinical trial

医客学院 - 会议报告集

Primary Endpoint Analysis of the ORCHESTRA TRIAL

医客学院 - 会议报告集

“挂号不就诊”，三甲医院1800多名病人去哪儿了

6月21日，上海市浦东新区人民法院对一起“医托”团伙诈骗案的两名主犯作出一审判决：被告人易某犯诈骗罪，判处有期徒刑十一年六个月，剥夺政治权利二年，并处罚金人民币二十万元。被告人邓某犯诈骗罪，判处有期徒刑十一年，剥夺政治权利.....

学术资讯 - 热点资讯

Phase l trial of hypoxia-responsive CEA CAR-T celltherapy in patients with heavily pretreated solid tumorvia intraperitoneal or intravenous transfusion

医客学院 - 会议报告集

Overall survival (oS) of phase 3 CodeBreak 300 study ofsotorasib plus panitumumab (soto pani) versus investigator'schoice of therapy for KRAS G12c-mutated metastatic colorectacancer (mCRc)

医客学院 - 会议报告集

Orchestrating a Collision with LiverTransplant for Colorectal Cancer

医客学院 - 会议报告集

Nivolumab plus ipilimumab vs chemotherapy as first-linetreatment for microsatellite instability-highmismatchrepairdeficient metastatic colorectal cancer expandedefficacy analysis from CheckMate 8HW

医客学院 - 会议报告集

Neoadjuvant treatment of lBl310 (anti-CTLA-4 antibody) plus sintilimab(anti-PD.1 antibody) in patients with microsatellite instabilityhighmismatchrepair-deficient colon cancer Results from a randomiz

医客学院 - 会议报告集

Neoadiuvant Pembrolizumab stratified to tumourmutation burden for High-Risk Stage 2 or Stage 3deficient-MMRMSl-High Colorectal CancerThe multicentre Phase 2 NEOPRISM-CRC trial

医客学院 - 会议报告集

MOUNTAINEER FINAL RESULTS OF APHASE 2 STUDY OF TUCATINIB ANDTRASTUZUMAB FOR HER2-POSITIVEMETASTATIC CRC

医客学院 - 会议报告集

今日实时热搜